MARKET

CBMG

CBMG

Cellular
NASDAQ

Real-time Quotes | Nasdaq Last Sale

18.24
-0.36
-1.94%
After Hours: 18.24 0 0.00% 16:00 09/23 EDT
OPEN
18.55
PREV CLOSE
18.60
HIGH
18.64
LOW
18.22
VOLUME
59.84K
TURNOVER
--
52 WEEK HIGH
19.50
52 WEEK LOW
11.48
MARKET CAP
354.46M
P/E (TTM)
-6.5699
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
STOCKHOLDER ALERT: Monteverde & Associates Continues its Investigation into the Following Merger
NEW YORK, NY / ACCESSWIRE / September 23, 2020 / Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Empire State Building in New York City, is investigating: * Akcea Therapeutics, Inc.
ACCESSWIRE · 1h ago
Merger Arbitrage Mondays - Condor Hospitality Terminates Merger Agreement With NHT Operating Partnership
Merger activity slowed down last week with no new deals announced.Two potential deals announced.Condor Hospitality Trust terminates its merger agreement with NHT Operating Partnership.
Seekingalpha · 2d ago
STOCKHOLDER ALERT: Monteverde & Associates Reminds Shareholders of its Continuing Investigation Regarding the Merger
NEW YORK, NY / ACCESSWIRE / September 20, 2020 / Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Empire State Building in New York City, is investigating: * Akcea Therapeutics, Inc.
ACCESSWIRE · 2d ago
Monteverde & Associates Reminds Shareholders of its Ongoing Investigation Regarding the Merger
NEW YORK, NY / ACCESSWIRE / September 15, 2020 / Juan Monteverde, founder, and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Empire State Building in New York City, is investigating: * Pfenex Inc.
ACCESSWIRE · 09/15 14:35
Merger Arbitrage Mondays - Gilead Sciences Acquires Immunomedics At A High Premium
Merger activity decreased last week, with two new deals announced.The acquisition of Immunomedics by Gilead Sciences.Nvidia agrees to buy Arm Holdings from SoftBank Group for $40 billion.
Seekingalpha · 09/15 03:22
WeissLaw LLP Reminds CBMG and MR Shareholders About Its Ongoing Investigations
PR Newswire · 09/02 00:31
Cellular Biomedicine Group to Present at Chinese Biopharmaceutical Association-USA Annual Conference
Cellular Biomedicine Group, Inc. (NASDAQ: CBMG) ("CBMG" or the "Company"), a biopharmaceutical firm engaged in the drug development of immunotherapies for cancer and stem cell therapies for degenerative diseases, is scheduled for a presentation at the 25th Annual Conference of the
PR Newswire · 08/26 14:00
Merger Arbitrage Mondays - Qiagen Shareholders Want More
Merger activity increased significantly last week with eight new deals announced.The acquisition of Principia Biopharma by Sanofi.Thermo Fisher Scientific terminates its acquisition agreement with QIAGEN.
Seekingalpha · 08/17 12:04
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of CBMG. Analyze the recent business situations of Cellular through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 1 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average CBMG stock price target is 19.00 with a high estimate of 19.00 and a low estimate of 19.00.
EPS
Institutional Holdings
Institutions: 57
Institutional Holdings: 3.55M
% Owned: 18.24%
Shares Outstanding: 19.43M
TypeInstitutionsShares
Increased
17
415.94K
New
16
-726.67K
Decreased
9
459.06K
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Biotechnology & Medical Research
-3.27%
Pharmaceuticals & Medical Research
-1.30%
Key Executives
Chairman/Independent Director
Terry Belmont
Chief Executive Officer/Chief Financial Officer/Director
Bizuo Liu
Chief Executive Officer/Chief Financial Officer/Director
Tony Liu
Senior Vice President/General Counsel/Secretary
Andrew Chan
Chief Scientific Officer
Yihong Yao
Independent Director
Chun Kwok Alan Au
Independent Director
Gang Ji
Independent Director
Wen Liu
Independent Director
Zhou Hansheng
Independent Director
Darren O'Brien
Independent Director
Hansheng Zhou
Non-Executive Independent Director
Edward Schafer
  • Dividends
  • Splits
  • Insider Activity
No Data
  • All
  • Financials
  • Insiders
More
Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About CBMG
Cellular Biomedicine Group, Inc. (CBMG), is a clinical-stage biopharmaceutical company. The Company is leveraging its cell-based technologies to develop immunotherapies for the treatment of cancer and stem cell therapies for the treatment of degenerative diseases. The Company provides comprehensive and integrated research and manufacturing services throughout the discovery, development and manufacturing spectrum for cell-based technologies. The Company’s primary focus has been to serve the growing health care market initially in China by marketing and commercializing immune cell and stem cell therapeutics, related tools and products. The Company’s treatment focal points are cancer and Knee Osteoarthritis (KOA). It is focusing its clinical development efforts on assets such as C-CAR088, C-CAR039, TIL051, AFT-TCRT in China and/or United States. It has also completed a Phase-I/IIa clinical study, in China, for our KOA therapy named ReJoin.
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of Cellular Biomedicine Group Inc stock information, including NASDAQ:CBMG real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CBMG stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading CBMG stock methods without spending real money on the virtual paper trading platform.